» Articles » PMID: 38004725

A Review of the Past, Present, and Future of the Monkeypox Virus: Challenges, Opportunities, and Lessons from COVID-19 for Global Health Security

Overview
Journal Microorganisms
Specialty Microbiology
Date 2023 Nov 25
PMID 38004725
Authors
Affiliations
Soon will be listed here.
Abstract

Monkeypox, a rare but significant zoonotic and orthopoxviral disease, has garnered increasing attention due to its potential for human-to-human transmission and its recent resurgence in multiple countries throughout Europe, North America, and Oceania. The disease has emerged as a novel threat to the global health systems that are still striving to recover from the major shocks of the COVID-19 pandemic. The unusual manifestation of the illness highlights a substantial knowledge deficit and necessitates the immediate development of a public health action strategy, considering the epidemiological differences observed in the ongoing outbreak and the appearance of cases in non-endemic nations. This literature review aims to synthesize existing knowledge on monkeypox, encompassing its historical context, etiology, epidemiology, surveillance, prevention, transmission, clinical presentation, diagnosis, treatments, and recent outbreak. Particular attention is given to both advances and gaps in our understanding of monkeypox, and we point toward future directions for research and intervention efforts as pertains to vaccine development and distribution. Lastly, we will also review the recent outbreak through a sociopolitical lens as relates to decision-making strategies, especially given the lessons learned from COVID-19.

Citing Articles

Current advances and challenges in mpox vaccine development: a global landscape.

Shafaati M, Forghani S, Shahsavand Davoudi A, Samiee R, Mohammadi K, Akbarpour S Ther Adv Vaccines Immunother. 2025; 13:25151355251314339.

PMID: 39872308 PMC: 11770767. DOI: 10.1177/25151355251314339.


Urogenital Manifestations in Mpox (Monkeypox) Infection: A Comprehensive Review of Epidemiology, Pathogenesis, and Therapeutic Approaches.

He S, Zhao J, Chen J, Liang J, Hu X, Zhang X Infect Drug Resist. 2025; 18():209-226.

PMID: 39816240 PMC: 11733167. DOI: 10.2147/IDR.S504280.


Challenges in Global Distribution and Equitable Access to Monkeypox Vaccines.

Danladi N, Agboola P, Olaniyi P, Eze S, Oladapo O, Obiwulu D Viruses. 2025; 16(12.

PMID: 39772126 PMC: 11680248. DOI: 10.3390/v16121815.


The Effects of the Combined Co-Expression of GroEL/ES and Trigger Factor Chaperones on Orthopoxvirus Phospholipase F13 Production in .

Merkuleva I, Nikitin V, Belaya T, Mustaev E, Shcherbakov D BioTech (Basel). 2024; 13(4).

PMID: 39727494 PMC: 11674265. DOI: 10.3390/biotech13040057.


Monkeypox (Mpox): Diagnosis and Emerging Challenges.

Krishna S, Teotia D, Yadav M, Mahilkar S, Suchiita A, Saxena A Yale J Biol Med. 2024; 97(4):529-534.

PMID: 39703603 PMC: 11650907. DOI: 10.59249/PWON3661.


References
1.
Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C . Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019; 33(4):1027-1043. PMC: 9533922. DOI: 10.1016/j.idc.2019.03.001. View

2.
Pugh C, Keasey S, Korman L, Pittman P, Ulrich R . Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000. Clin Vaccine Immunol. 2014; 21(6):877-85. PMC: 4054243. DOI: 10.1128/CVI.00035-14. View

3.
Rao A, Petersen B, Whitehill F, Razeq J, Isaacs S, Merchlinsky M . Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States,.... MMWR Morb Mortal Wkly Rep. 2022; 71(22):734-742. PMC: 9169520. DOI: 10.15585/mmwr.mm7122e1. View

4.
McCollum A, Damon I . Human monkeypox. Clin Infect Dis. 2013; 58(2):260-7. DOI: 10.1093/cid/cit703. View

5.
Guharoy R, Krenzelok E . Lessons from the mismanagement of the COVID-19 pandemic: A blueprint to reform CDC. Am J Health Syst Pharm. 2021; 78(18):1739-1741. PMC: 8194724. DOI: 10.1093/ajhp/zxab209. View